Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
71.3 CHF | +2.00% | +12.28% | +40.08% |
Mar. 20 | Transcript : Cosmo Pharmaceuticals N.V. - Analyst/Investor Day | |
Mar. 20 | Cosmo Pharmaceuticals N.V. Proposes Dividend Payment for 2024 | CI |
Sales 2023 | 96.72M 105M 94.31M | Sales 2024 * | 233M 252M 227M | Capitalization | 1.15B 1.24B 1.12B |
---|---|---|---|---|---|
Net income 2023 | 1M 1.08M 975K | Net income 2024 * | 111M 120M 108M | EV / Sales 2023 | 9.1 x |
Net cash position 2023 * | 71.24M 77.03M 69.46M | Net cash position 2024 * | 110M 119M 107M | EV / Sales 2024 * | 4.45 x |
P/E ratio 2023 |
771
x | P/E ratio 2024 * |
9.8
x | Employees | 319 |
Yield 2023 * |
1.5% | Yield 2024 * |
2.94% | Free-Float | 44.7% |
Latest transcript on Cosmo Pharmaceuticals N.V.
1 day | -0.07% | ||
1 week | +10.24% | ||
Current month | +6.22% | ||
1 month | +6.22% | ||
3 months | +36.45% | ||
6 months | +71.78% | ||
Current year | +37.52% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 61 | 05-12-31 | |
Niall Donnelly
DFI | Director of Finance/CFO | 52 | 16-05-31 |
Chief Tech/Sci/R&D Officer | 54 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
David W Maris
BRD | Director/Board Member | 57 | 21-05-27 |
Founder | 69 | 96-12-31 | |
Director/Board Member | 64 | 05-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 10 M€ | -3.35% | - | |
0.00% | 735 M€ | -.--% | - | |
0.00% | 36 M€ | +4.74% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 71.3 | +2.00% | 27 825 |
24-03-27 | 69.9 | +7.54% | 80,766 |
24-03-26 | 65 | -2.40% | 22,291 |
24-03-25 | 66.6 | +0.76% | 18,793 |
24-03-22 | 66.1 | +4.09% | 36,057 |
Delayed Quote Swiss Exchange, March 28, 2024 at 09:47 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+37.52% | 1.24B | |
+35.43% | 701B | |
+26.24% | 571B | |
+1.06% | 381B | |
+20.51% | 334B | |
+16.88% | 319B | |
+1.00% | 210B | |
+2.32% | 210B | |
-6.50% | 201B | |
-3.49% | 157B |